Michael Burry says he has major doubts about SpaceX and Anthropic's lofty valuations. In recent discussion threads on his Substack, the investor of "The Big Short" fame questioned the worth of Elon ...
Efficacy and safety of less frequent dosing with elranatamab (ELRA) in patients with relapsed or refractory multiple myeloma (RRMM): A US subgroup analysis from MagnetisMM-3. Positron emission ...
NEW YORK, June 9 (Reuters) - Short sellers beware: Elon Musk's SpaceX IPO may be too hot to handle. On the face of it, the company is a natural target for short sellers -- investors who sell borrowed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results